Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuya Edahiro

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|April 17, 2026
From GWAS Signal to Mechanism in Rheumatoid Arthritis: Lessons from a Single Risk LocusRyuya Edahiro, Yukinori Okada
Immunological Medicine|August 22, 2024
Large-scale cross-trait genetic analysis highlights shared genetic backgrounds of autoimmune diseasesYuji Yamamoto, Yuya Shirai, Ryuya Edahiro, et al.
Nature Communications|June 6, 2026
A multi-ethnic reference map of T cell receptor germline diversity reveals evidence of natural selection on alpha chain genesSreekar Mantena, Ryuya Edahiro, Yukinori Okada, et al.
International Immunology|March 11, 2026
Association between autoimmune diseases and the gut microbiomeYudai Hirano, Yoshihiko Tomofuji, Ryuya Edahiro, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2019
Severe myocarditis with slight lymphocytic infiltration after nivolumab treatmentRyuya Edahiro, Takayuki Shiroyama, Sachiko Hijiki, et al.
Thoracic Cancer|April 10, 2019
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune-related adverse effect: A case reportRyuya Edahiro, Mikako Ishijima, Hiroyuki Kurebe, et al.
Respiratory Research|January 10, 2020
Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort studyYohei Oshitani, Seigo Kitada, Ryuya Edahiro, et al.
Annals of Translational Medicine|January 1, 2019
Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpressionTakeshi Uenami, Mikako Ishijima, Masaki Kanazu, et al.
Thoracic Cancer|October 18, 2018
Hyperprogressive disease in patients with non-small cell lung cancer treated with nivolumab: A case seriesMasaki Kanazu, Ryuya Edahiro, Hiroyuki Krebe, et al.
Nature Communications|June 20, 2023
Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesisGo Sato, Yuya Shirai, Shinichi Namba, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|April 17, 2026
From GWAS Signal to Mechanism in Rheumatoid Arthritis: Lessons from a Single Risk LocusRyuya Edahiro, Yukinori Okada
Immunological Medicine|August 22, 2024
Large-scale cross-trait genetic analysis highlights shared genetic backgrounds of autoimmune diseasesYuji Yamamoto, Yuya Shirai, Ryuya Edahiro, et al.
Nature Communications|June 6, 2026
A multi-ethnic reference map of T cell receptor germline diversity reveals evidence of natural selection on alpha chain genesSreekar Mantena, Ryuya Edahiro, Yukinori Okada, et al.
International Immunology|March 11, 2026
Association between autoimmune diseases and the gut microbiomeYudai Hirano, Yoshihiko Tomofuji, Ryuya Edahiro, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2019
Severe myocarditis with slight lymphocytic infiltration after nivolumab treatmentRyuya Edahiro, Takayuki Shiroyama, Sachiko Hijiki, et al.
Thoracic Cancer|April 10, 2019
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune-related adverse effect: A case reportRyuya Edahiro, Mikako Ishijima, Hiroyuki Kurebe, et al.
Respiratory Research|January 10, 2020
Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort studyYohei Oshitani, Seigo Kitada, Ryuya Edahiro, et al.
Annals of Translational Medicine|January 1, 2019
Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpressionTakeshi Uenami, Mikako Ishijima, Masaki Kanazu, et al.
Thoracic Cancer|October 18, 2018
Hyperprogressive disease in patients with non-small cell lung cancer treated with nivolumab: A case seriesMasaki Kanazu, Ryuya Edahiro, Hiroyuki Krebe, et al.
Nature Communications|June 20, 2023
Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesisGo Sato, Yuya Shirai, Shinichi Namba, et al.
Pageof 7